市場調查報告書

末稍血管用設備的歐洲市場:2020年∼2026年

Peripheral Vascular Devices Market Report Suite | Europe | 2020-2026 | MedSuite

出版商 iData Research Inc. 商品編碼 937772
出版日期 內容資訊 英文 914 Pages
商品交期: 最快1-2個工作天內
價格
末稍血管用設備的歐洲市場:2020年∼2026年 Peripheral Vascular Devices Market Report Suite | Europe | 2020-2026 | MedSuite
出版日期: 2020年04月28日內容資訊: 英文 914 Pages
簡介

歐洲的末稍血管用設備市場在2019年估算為約13億歐元,到2026年達到約16億歐元,在預測期間內預計將以年複合成長率2.9%成長。

本報告提供歐洲的末稍血管用設備市場相關調查分析,提供市場分析 (銷售數量,ASP,市場金額·成長率趨勢) 、推動市場要素與阻礙要素,競爭分析,最近的M&A等相關的系統性資訊。

目錄

圖的清單

表(圖表)的清單

摘要整理

末稍血管用設備的歐洲市場概要

競爭分析

市場趨勢

市場發展

治療數量

對象市場

版本履歷

調查手法

疾病概要

  • 基本結構
  • 病的治療和診斷
  • 患者的人口統計

產品系列

  • 簡介
  • 產品系列
  • 法規問題和回收
  • 臨床試驗

末稍血管用設備市場概要

  • 簡介
    • 動脈粥狀硬化性心血管疾病
    • 週邊動脈疾病(PAD)
  • 匯率
  • 市場概要
  • 趨勢分析
  • 促進因素·阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 競爭市場佔有率分析
  • 企業簡介
  • SWOT分析
  • M&A

國家概況

  • 簡介
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 北歐各國
  • 奧地利
  • 瑞士
  • 葡萄牙

治療數量

  • 治療
目錄
Product Code: iDATA_EUPV20_MS

The full report suite on the European market for peripheral vascular (PV) devices includes peripheral arterial stents, peripheral venous stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion (CTO) devices, embolic protection devices (EPDs), stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, diagnostic and interventional catheters, standard and hydrophilic guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices. There is also a series of appendices containing analyses on drug-coated balloons (DCBs), lithotripsy balloon catheters and peripheral intravascular ultrasound (IVUS) catheters.

The European peripheral vascular device market was valued at about €1.3 billion in 2019. This is expected to increase over the forecast period at a CAGR of 2.9% to reach about €1.6 billion by 2026.

The growth of venous treatments in Europe is expected to accelerate in the coming years as clinical knowledge continues to develop and expertise in the medical community is diffused. While currently consolidated within select regions in the United Kingdom, Germany, France, Austria and Switzerland, venous treatment centers are expected to be developed across Europe to facilitate both the diagnosis and treatment of venous disease.

Treatment of peripheral arterial disease is slowly continuing to increase its penetration in the treatable population. As Europe continues to age, the total number of procedures is expected to

grow over the forecast period. As reimbursement tensions continue, treatment techniques have continued to be refined towards the most cost effective, long-term option for patients.

TABLE OF CONTENTS I

LIST OF FIGURES XVII

LIST OF CHARTS XLIII

EXECUTIVE SUMMARY 1

EUROPEAN MARKET FOR PERIPHERAL VASCULAR DEVICES OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 9

MARKET DEVELOPMENTS 13

PROCEDURE NUMBERS 14

MARKETS INCLUDED 16

VERSION HISTORY 18

RESEARCH METHODOLOGY 19

  • Step 1: Project Initiation & Team Selection 19
  • Step 2: Prepare Data Systems and Perform Secondary Research 22
  • Step 3: Preparation for Interviews & Questionnaire Design 24
  • Step 4: Performing Primary Research 25
  • Step 5: Research Analysis: Establishing Baseline Estimates 27
  • Step 6: Market Forecast and Analysis 28
  • Step 7: Identify Strategic Opportunities 30
  • Step 8: Final Review and Market Release 31
  • Step 9: Customer Feedback and Market Monitoring 32

DISEASE OVERVIEW 33

  • 2.1 BASIC ANATOMY 33
  • 2.2 DISEASE TREATMENTS & DIAGNOSTICS 34
    • 2.2.1 Aortic Aneurysms 34
    • 2.2.2 Atherosclerosis 35
    • 2.2.3 Peripheral Arterial Disease (PAD) 36
    • 2.2.4 Deep Vein Thrombosis (DVT) 37
    • 2.2.5 Pulmonary Embolism (PE) 38
  • 2.3 PATIENT DEMOGRAPHICS 40
    • 2.3.1 Aortic Aneurysms 40
    • 2.3.2 Atherosclerosis 40
    • 2.3.3 Peripheral Arterial Disease (PAD) 40
    • 2.3.4 Deep Vein Thrombosis (DVT) 41
    • 2.3.5 Pulmonary Embolism (PE) 41

PRODUCT PORTFOLIO 43

  • 3.1 INTRODUCTION 43
  • 3.2 PRODUCT PORTFOLIOS 43
    • 3.2.1 Peripheral Vascular Stent 43
    • 3.2.2 Venous Stent 46
    • 3.2.3 Percutaneous Transluminal Angioplasty (PTA) Balloon 47
    • 3.2.4 Drug-Coated Balloon 51
    • 3.2.5 Atherectomy Device 53
    • 3.2.6 Chronic Total Occlusion (CTO) Device 55
    • 3.2.7 Intravascular Lithotripsy 57
    • 3.2.8 Surgical Graft 58
    • 3.2.9 Stent Graft 61
    • 3.2.10 Embolic Protection Device 63
    • 3.2.11 Peripheral Thrombus Management Device 65
    • 3.2.12 Inferior Vena Cava Filter 68
    • 3.2.13 Carotid Shunt 69
    • 3.2.14 Diagnostic and Interventional Catheters 70
    • 3.2.15 Diagnostic and Interventional Guidewire 73
    • 3.2.16 Introducer Sheath 77
    • 3.2.17 Vascular Closure Device (VCD) 81
    • 3.2.18 Transcatheter Embolization Device 83
    • 3.2.19 Peripheral IVUS Catheter 86
  • 3.3 REGULATORY ISSUES AND RECALLS 87
    • 3.3.1 Abbott 87
      • 3.3.1.1 Carotid Shunt 87
      • 3.3.1.2 Vascular Closure Device 87
    • 3.3.2 Argon Medical 88
      • 3.3.2.1 Introducer Sheaths 88
    • 3.3.3 Arrow International 89
      • 3.3.3.1 Introducer Sheaths 89
    • 3.3.4 Atrium Medical 91
      • 3.3.4.1 Peripheral Vascular Stent 91
    • 3.3.5 BD 92
      • 3.3.5.1 Inferior Vena Cava Filter 92
      • 3.3.5.2 Introducer Sheaths 92
      • 3.3.5.3 Stent Graft 93
    • 3.3.6 Boston Scientific 94
      • 3.3.6.1 Atherectomy Devices 94
      • 3.3.6.2 Diagnostic and Interventional Catheters 95
      • 3.3.6.3 Introducer Sheaths 96
      • 3.3.6.4 Peripheral Thrombus Management Devices 97
    • 3.3.7 Cardinal Health 98
      • 3.3.7.1 Vascular Closure Devices 98
    • 3.3.8 Cardiovascular System (C.S.I.) 99
      • 3.3.8.1 Atherectomy Devices 99
    • 3.3.9 Cook Medical 101
      • 3.3.9.1 Diagnostic and Interventional Catheters 101
      • 3.3.9.2 Introducer Sheaths 101
      • 3.3.9.3 Inferior Vena Cava Filters 102
      • 3.3.9.4 Peripheral Vascular Stents 103
      • 3.3.9.5 Stent Grafts 103
    • 3.3.10 Cordis (Cardinal Health) 104
      • 3.3.10.1 Diagnostic and Interventional Catheters 104
      • 3.3.10.2 Inferior Vena Cava Filters 104
      • 3.3.10.3 Peripheral Stents 105
    • 3.3.11 Endologix 106
      • 3.3.11.1 Stent Grafts 106
    • 3.3.12 Edwards Lifesciences 108
      • 3.3.12.1 Chronic Total Occlusion Devices 108
    • 3.3.13 Maquet 109
      • 3.3.13.1 PTA Balloons 109
    • 3.3.14 Medtronic 110
      • 3.3.14.1 Carotid Shunts 110
      • 3.3.14.2 Diagnostic and Interventional Catheters 110
      • 3.3.14.3 PTA Balloon Catheters 110
      • 3.3.14.4 Peripheral Stents 112
      • 3.3.14.5 Stent Grafts 112
      • 3.3.14.6 Transcatheter Embolization Devices 113
    • 3.3.15 Spectranetics (Philips) 114
      • 3.3.15.1 Atherectomy Devices 114
      • 3.3.15.2 Chronic Total Occlusion Devices 115
    • 3.3.16 Shockwave Medical, Inc. 116
      • 3.3.16.1 Intravascular Lithotripsy 116
    • 3.3.17 Terumo 117
      • 3.3.17.1 Introducer Sheaths 117
      • 3.3.17.2 PTA Balloon Catheters 117
    • 3.3.18 Other Companies 117
      • 3.3.18.1 Atherectomy Devices 117
      • 3.3.18.2 Introducer Sheaths 118
      • 3.3.18.3 PTA Balloon Catheters 118
      • 3.3.18.4 Peripheral IVUS Catheters 119
      • 3.3.18.5 Stent Grafts 119
      • 3.3.18.6 Vascular Closure Devices (VCD) 120
  • 3.4 CLINICAL TRIALS 121
    • 3.4.1 Abbott 121
      • 3.4.1.1 Peripheral Vascular Stent 121
      • 3.4.1.2 Other Peripheral Vascular Related Studies 124
    • 3.4.2 B. Braun 125
      • 3.4.2.1 Diagnostic and Interventional Catheters 125
      • 3.4.2.2 Peripheral Vascular Stent 125
    • 3.4.3 Boston Scientific 126
      • 3.4.3.1 Atherectomy Devices 126
      • 3.4.3.2 Drug-Coated Balloons 127
      • 3.4.3.3 Peripheral Vascular Stents 129
      • 3.4.3.4 Other Peripheral Vascular Related Studies 130
      • 3.4.3.5 Venous Stents 130
    • 3.4.4 C.R. Bard (BD) 131
      • 3.4.4.1 Diagnostic and Interventional Catheters 131
      • 3.4.4.2 Drug-Coated Balloons 131
      • 3.4.4.3 Venous Stents 133
      • 3.4.4.4 Other Peripheral Vascular Related Studies 134
    • 3.4.5 Cardinal Health 135
      • 3.4.5.1 Other Peripheral Vascular Related Studies 135
    • 3.4.6 Cook Medical 136
      • 3.4.6.1 Drug-Eluting Stents 136
      • 3.4.6.2 Inferior Vena Cava Filters 137
      • 3.4.6.3 Peripheral Vascular Stents 138
      • 3.4.6.4 Venous Stents 139
    • 3.4.7 Cordis (Cardinal Health) 140
      • 3.4.7.1 Peripheral Vascular Stents 140
    • 3.4.8 Medtronic 141
      • 3.4.8.1 Atherectomy Devices 141
      • 3.4.8.2 Drug-Coated Balloons 142
      • 3.4.8.3 Other Peripheral Vascular Related Studies 148
    • 3.4.9 Merit Medical 150
      • 3.4.9.1 Stent Grafts 150
    • 3.4.10 Philips/Spectranetics 151
      • 3.4.10.1 Atherectomy Devices 151
      • 3.4.10.2 Peripheral IVUS Catheters 151
      • 3.4.10.3 Spectranetics 152
      • 3.4.10.3.1 Drug-Coated Balloons 152
      • 3.4.10.3.2 Atherectomy Devices 155
    • 3.4.11 Shockwave Medical, Inc. 156
      • 3.4.11.1 Lithoplasty System 156
    • 3.4.12 Surmodics 157
      • 3.4.12.1 Drug-Coated Balloons 157
    • 3.4.13 Terumo 158
      • 3.4.13.1 Drug-Coated Balloons 158
      • 3.4.13.2 Peripheral Vascular Stents 158
    • 3.4.14 W.L. Gore 159
      • 3.4.14.1 Peripheral Vascular Stents 159
      • 3.4.14.2 Stent Grafts 160
      • 3.4.14.3 Expandable Balloons 161
    • 3.4.15 Other Companies 162
      • 3.4.15.1 Carotid Shunt / Endarterectomy 162
      • 3.4.15.2 Drug-Coated Balloons 163
      • 3.4.15.3 Peripheral Vascular Stents 167
      • 3.4.15.4 Other Peripheral Vascular Related Studies 170

PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW 171

  • 4.1 INTRODUCTION 171
    • 4.1.1 Atherosclerosis 171
    • 4.1.2 Peripheral Arterial Disease (PAD) 172
  • 4.2 CURRENCY EXCHANGE RATE 173
  • 4.3 MARKET OVERVIEW 174
  • 4.4 TREND ANALYSIS 182
  • 4.5 DRIVERS AND LIMITERS 186
    • 4.5.1 Market Drivers 186
    • 4.5.2 Market Limiters 187
  • 4.6 COMPETITIVE MARKET SHARE ANALYSIS 189
  • 4.7 COMPANY PROFILES 197
    • 4.7.1 Abbott 197
    • 4.7.2 Becton Dickinson (BD) 198
    • 4.7.3 Boston Scientific 199
    • 4.7.4 Cardinal Health 200
      • 4.7.4.1 Cordis (Cardinal Health) 200
    • 4.7.5 Cook Medical 201
    • 4.7.6 Maquet 202
    • 4.7.7 Medtronic 203
    • 4.7.8 Teleflex 205
    • 4.7.9 Terumo Interventional System (TIS) 206
    • 4.7.10 W.L. Gore 207
  • 4.8 SWOT ANALYSIS 208
    • 4.8.1 Abbott 209
    • 4.8.2 B. Braun 210
    • 4.8.3 Boston Scientific 211
    • 4.8.4 BD 212
    • 4.8.5 Cardinal Health 213
    • 4.8.6 Cook Medical 214
    • 4.8.7 Integra Lifesciences 215
    • 4.8.8 Maquet 216
    • 4.8.9 Medtronic 217
    • 4.8.10 Merit Medical 218
    • 4.8.11 Phillips 219
    • 4.8.12 Teleflex 220
    • 4.8.13 Terumo 221
    • 4.8.14 W.L. Gore 222
  • 4.9 MERGERS AND ACQUISITIONS 223

COUNTRY PROFILES 228

  • 5.1 INTRODUCTION 228
      • 5.1.1.1 Population 228
      • 5.1.1.2 Median Age 228
      • 5.1.1.3 GDP Per Capita 228
      • 5.1.1.4 Price Index 228
  • 5.2 GERMANY 229
  • 5.3 FRANCE 230
  • 5.4 UNITED KINGDOM 231
  • 5.5 ITALY 232
  • 5.6 SPAIN 233
  • 5.7 BENELUX 234
  • 5.8 SCANDINAVIA 235
  • 5.9 AUSTRIA 236
  • 5.10 SWITZERLAND 237
  • 5.11 PORTUGAL 238

PROCEDURE NUMBERS 239

  • 6.1 PROCEDURES 239
    • 6.1.1 Total Procedures 239
    • 6.1.2 Bare Metal Stent Procedures 241
      • 6.1.2.1 Iliac Bare Metal Stent Procedures 246
      • 6.1.2.2 Femoral Popliteal Bare Metal Stent Procedures 247
      • 6.1.2.3 Infra-Popliteal Bare Metal Stent Procedures 248
      • 6.1.2.4 Renal Bare Metal Stent Procedures 249
      • 6.1.2.5 Carotid Bare Metal Stent Procedures 250
    • 6.1.3 Venous Stenting Procedures 251
    • 6.1.4 Angioplasty Procedures 253
    • 6.1.5 Atherectomy Procedures 255
    • 6.1.6 Chronic Total Occlusion Procedures 257
    • 6.1.7 Embolic Protection Device Procedures 258
    • 6.1.8 Stent Graft Procedures 260
      • 6.1.8.1 AAA Stent Graft Procedures 261
      • 6.1.8.2 TAA Stent Graft Procedures 262
      • 6.1.8.3 Fenestrated Stent Graft Procedures 263
    • 6.1.9 Surgical Graft Procedures 264
      • 6.1.9.1 Lower Limb Surgical Graft Procedures 265
      • 6.1.9.2 AV Access Surgical Graft Procedures 266
      • 6.1.9.3 Aorta Repair Surgical Graft Procedures 267
      • 6.1.9.3.1 AAA Surgical Graft Procedures 269
      • 6.1.9.3.2 TAA Surgical Graft Procedures 270
      • 6.1.9.4 Extra-Anatomical Surgical Graft Procedures 271
    • 6.1.10 AV Access Thrombectomy Procedures 272